Over the last 15 years, the TIDES Summit has cemented its status as the community’s premier meeting place for the oligonucleotide and peptide discovery, development and manufacturing industries.Join 750 of professionals at this must attend oligonucleotide and peptide discovery, development and manufacturing event. This is your chance to get the information and contacts you need to overcome the toughest challenges you are facing and move your research, development and process chemistry.
Tides will take place May 12-15, 2013 in Boston. If you'd like to join us, as a reader of this blog, you receive 20% off the standard rate when you register to join us and mention code TIDES13JP. If you have any questions, feel free to email Jennifer Pereira.
Keynote Presentations Include:
- MIPOMERSEN CLINICAL ADVANCES
- ˃Presenter: Mary P. McGowan, M.D., Senior Medical Director, Clinical Research, Genzyme, A Sanofi Company
- EPITOPE TARGETING PCC AGENTS
- ˃Presenter: James R. Heath, Ph.D., Professor, Chemistry and Chemical Engineering, California Institute Of Technology
- SPHERICAL NUCLEIC ACIDS (SNAS)
- ˃Presenter: Chad A. Mirkin, Ph.D., Professor, Chemistry, Northwestern University
- VC FUNDING FOR OLIGOS AND PEPTIDES
- ˃Presenter: Bruce Booth, D.Phil., Partner, Life Sciences, Atlas Venture
- DELIVERY AND DEVICE STRATEGIES FOR PEPTIDES
- ˃Presenter: William J. Lambert, Ph.D., Fellow, Drug Delivery and Device Development, MedImmune, Inc.
- OLIGONUCLEOTIDE MANUFACTURING, TECHNOLOGY AND PRODUCT DEVELOPMENT
- • Hear first-hand reviews from regulatory and industry thought leaders on quality and purity specifications to answer your pressing questions about impurities specifications
- • Implement continued process verification with latest perspective of industry consortium
- • Modernize your process science with cutting-edge reports in the new process chemistry session
- PEPTIDE MANUFACTURING, TECHNOLOGY AND PRODUCT DEVELOPMENT
- • FDA perspective and scale up report on peptide vaccines
- • Plan for the future of novel synthesis technologies with new data from Lonza, Bachem and EMD
- • Learn how to assess and prevent aggregation to avoid late stage problems that can hold up product release
- OLIGONUCLEOTIDE THERAPEUTICS DISCOVERY
- • Discover new developments in single stranded RNAs, non-coding RNAs and non-hepatic cell and tissue targeting
- • Find out what it really takes to bring an oligonucleotide drug to market and learn about the phase-specific strategies you should be implementing
- • Explore emerging solutions to the oligonucleotide delivery challenge and hear the latest preclinical and clinical data to inform your own oligonucleotide therapeutic projects
- PEPTIDE DISCOVERY AND DEVELOPMENT
- • Discover the latest advances in peptide-like scaffolds and structures and peptides as protein-protein interaction modulators to accelerate your discovery efforts
- • Hear new preclinical and clinical data from multiple peptide drugs in development to provide you lessons for your own projects
- • Find novel synthetic approaches to modify peptides and strategies for intracellular peptide delivery to improve the drug-like properties of your molecules
- NUCLEIC ACIDS TECHNOLOGIES FOR MOLECULAR DIAGNOSTICS
- • Learn new technologies for sample prep and for the diagnostics of the future
- • Ensure supply chain for labels and modifications to avoid interruptions in distribution
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment